KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Operating Leases: 2019-2025

Historic Operating Leases for Neogenomics (NEO) over the last 7 years, with Sep 2025 value amounting to $64.3 million.

  • Neogenomics' Operating Leases rose 3.46% to $64.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.3 million, marking a year-over-year increase of 3.46%. This contributed to the annual value of $60.8 million for FY2024, which is 10.36% down from last year.
  • As of Q3 2025, Neogenomics' Operating Leases stood at $64.3 million, which was down 3.44% from $66.6 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Operating Leases ranged from a high of $79.3 million in Q3 2021 and a low of $51.5 million during Q1 2021.
  • Over the past 3 years, Neogenomics' median Operating Leases value was $64.3 million (recorded in 2025), while the average stood at $64.0 million.
  • As far as peak fluctuations go, Neogenomics' Operating Leases spiked by 70.91% in 2021, and later decreased by 12.01% in 2023.
  • Quarterly analysis of 5 years shows Neogenomics' Operating Leases stood at $72.3 million in 2021, then dropped by 4.62% to $69.0 million in 2022, then decreased by 1.57% to $67.9 million in 2023, then decreased by 10.36% to $60.8 million in 2024, then increased by 3.46% to $64.3 million in 2025.
  • Its Operating Leases stands at $64.3 million for Q3 2025, versus $66.6 million for Q2 2025 and $59.9 million for Q1 2025.